| Basics |
Bristol-Myers Squibb Co.
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
|
| IPO Date: |
December 31, 1981 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$106.16B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.41 | 0.93%
|
| Avg Daily Range (30 D): |
$0.54 | 1.15%
|
| Avg Daily Range (90 D): |
$0.48 | 1.04%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
9.42M |
| Avg Daily Volume (30 D): |
13.21M |
| Avg Daily Volume (90 D): |
11.98M |
| Trade Size |
| Avg Trade Size (Sh.): |
179 |
| Avg Trade Size (Sh.) (30 D): |
104 |
| Avg Trade Size (Sh.) (90 D): |
108 |
| Institutional Trades |
| Total Inst.Trades: |
126,659 |
| Avg Inst. Trade: |
$5.02M |
| Avg Inst. Trade (30 D): |
$6.07M |
| Avg Inst. Trade (90 D): |
$5.91M |
| Avg Inst. Trade Volume: |
.11M |
| Avg Inst. Trades (Per Day): |
22 |
| Market Closing Trades |
| Avg Closing Trade: |
$56.11M |
| Avg Closing Trade (30 D): |
$112.27M |
| Avg Closing Trade (90 D): |
$99.38M |
| Avg Closing Volume: |
1.05M |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$2.97
|
$1.08
|
$.64
|
|
Diluted EPS
|
$2.97
|
$1.08
|
$.64
|
|
Revenue
|
$ 48.03B
|
$ 12.22B
|
$ 12.27B
|
|
Gross Profit
|
$ 33.38B
|
$ 8.79B
|
$ 8.9B
|
|
Net Income / Loss
|
$ 6.05B
|
$ 2.2B
|
$ 1.31B
|
|
Operating Income / Loss
|
$ 8.03B
|
$ 3.11B
|
$ 1.77B
|
|
Cost of Revenue
|
$ 14.65B
|
$ 3.44B
|
$ 3.37B
|
|
Net Cash Flow
|
$ 7.83B
|
$ 3.12B
|
$ 1.74B
|
|
PE Ratio
|
17.50
|
|
|
|
|
|
